Skip to main navigation

ANI Pharmaceuticals, Inc.

About
Executive Team Board of Directors Purpose & Values

How We Operate
Quality Capabilities

News
Products
Investors
We're Hiring
We're Hiring Career Benefits Job Openings Employment Application Exploring Life in Baudette, MN
Contact
Contact Us Locations

News

Investors Menu

Overview
News
Events & Presentations
Stock Information
Stock Quote & Chart Investment Calculator Analyst Coverage
Financials
Quarterly Results Annual Reports SEC Filings
Governance
Governance Documents Executive Team Board of Directors Committee Composition
Resources
Investor FAQs Information Request Form Investor Email Alerts Investor Contacts

Year

03/27/2024

ANI Pharmaceuticals Announces the Launch of Levofloxacin Oral Solution, USP

02/29/2024

ANI Pharmaceuticals Reports Fourth Quarter and Record Full-Year 2023 Financial Results and Provides 2024 Guidance

02/20/2024

ANI Pharmaceuticals to Present at the Leerink Partners Global Biopharma Conference

02/07/2024

ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024, at 8:30 a.m. ET

01/29/2024

ANI Pharmaceuticals to Participate at the Guggenheim Healthcare Talks | 6th Annual Biotechnology Conference

01/23/2024

ANI Pharmaceuticals Announces the Launch of Pentoxifylline Extended-Release Tablets, USP

01/16/2024

ANI Pharmaceuticals Announces the FDA Approval and Launch of Indomethacin Oral Suspension, USP

Pagination

First page
Previous page
Page 1
Page 2
Current page 3

Displaying 21 - 27 of 27

Contact Us

INVESTOR CONTACT

In-Site Communications, Inc.
Lisa M. Wilson

212-452-2793
IR@anipharmaceuticals.com

Quick Links

SEC Filings
Investor FAQs
Information Request Form

Investor Email Alerts

Unsubscribe

Products | Investors | Careers | Contact Us | Privacy Policy | Terms of Use | Accessibility
© Copyright 2024 ANI Pharmaceuticals, Inc.

Linkedin Youtube